Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis
采用氟达拉滨/美法仑预处理和他克莫司/西罗莫司预防GVHD治疗的AML患者异基因造血干细胞移植的长期生存结果
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-025-02738-4
Salhotra, Amandeep; Yang, Dongyun; Al Malki, Monzr M; Mokhtari, Sally; Knobler, Diana; Agarwal, Vaibhav; Sandhu, Karamjeet; Park, Gabriel; Aribi, Ahmed; Ali, Haris; Aldoss, Ibrahim; Otoukesh, Salman; Arslan, Shukaib; Ball, Brian; Koller, Paul; Amanam, Idoroenyi; Pourhassan, Hoda; Blackmon, Amanda; Becker, Pamela; Pullarkat, Vinod; Artz, Andrew S; Smith, Eileen; Marcucci, Guido; Forman, Stephen; Stein, Anthony; Nakamura, Ryotaro